World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

Cision PR Newswire by Cision PR Newswire
May 15, 2026
in Press Releases - Lifestyle
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

LONDON, May 15, 2026 /PRNewswire/ — Virtual Science AI announces the launch of Medical Competitor AI, an AI solution that analyses competitor medical activity and scientific narratives. The solution – a first in the life sciences industry – is already being used by top pharma companies to drive launch success.


Virtual Science AI Logo (PRNewsfoto/Virtual Science AI Ltd)

  • First AI-driven competitor asset medical activity and scientific narrative tracking platform
  • Built for launch excellence, new asset and indication peri-launch planning
  • Provides reliable competitor activity data and scientific narrative intelligence

Virtual Science AI’s industry-leading medical intelligence platform is used by most of the world’s top pharma companies and increasingly by innovative biotech organisations. The medical intelligence system use cases include: integrated medical intelligence, MSL intelligence, AI advisory board intelligence, social intelligence, real-time congress intelligence and now competitor assets intelligence. There is a robust plan for numerous upcoming application releases to address life sciences’ most needed intelligence needs.

Competitor asset medical intelligence:

Historically, analysing competitor asset medical activity such as conference coverage, trade activities, social engagement activity, posters, publications and more has been very manual and often not even done.

Life science teams launching new treatments or expanding into new indications need to make plans and select activities, shape and communicate scientific narratives to help bring treatments to the patients who can benefit most.

The competitor intelligence platform provides intel on competitor activities, their narratives and how the community is responding to support with informing where to go with activity and narrative shaping that is unique to the product being launched.

In an environment where budget is increasingly needed to be stretched and headcount in pharma is being reduced, the platform helps teams make smart decisions on where to focus activity and supports narrative building.

Tom Hughes, CEO, Virtual Science AI stated:

“The teams behind the most important launches in pharma have historically had to piece together competitive intelligence manually – or simply go without. Medical competitor AI changes that. It gives launch teams real-time visibility into competitor activity, scientific narratives and community response, so they can make smarter decisions about where to focus and how to shape their story – and ultimately get more patients on the right treatments.”

For further information about Virtual Science AI’s intelligence solutions, visit: www.virtualscienceai.com.

About Virtual Science AI

Virtual Science AI is world-leading medical intelligence platform company exclusively for life sciences. Providing enterprise-wide advisory panel, integrated medical intelligence, social media intelligence, congress intelligence and competitor intelligence solutions. Virtual Science AI’s proprietary medical intelligence platform solutions transform complex scientific data into actionable intelligence, empowering life science teams to drive repeatable value from its AI system enterprise-wide.

Headquartered in London and with operations across Europe, North America, Asia Pacific, and Latin America, Virtual Science AI delivers cutting-edge software as a service (SaaS) solutions for the life-science and healthcare sectors. The company partners with most of the top 20 leading pharmaceutical companies and numerous biotechnology firms.

Logo – https://mma.prnewswire.com/media/2875012/5972973/Virtual_Science_AI_Logo.jpg

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/virtual-science-ai-launches-first-ai-driven-competitor-activity-tracking-platform-to-support-pharma-asset-launch-success-302773712.html

SOURCE Virtual Science AI Ltd

Cision PR Newswire

Cision PR Newswire

Related Posts

The One Where SHEGLAM Meets FRIENDS

October 26, 2026

Rapidus and HCLTech announce partnership for next-generation semiconductor technologies

October 26, 2026

Parloa’s Agent Management Platform now sold as an SAP Solution Extension for agentic customer interactions

October 26, 2026

Temu Partners with Spain’s Recyclia to Support Seller Extended Producer Responsibility

October 26, 2026

SUNON Brings AI, Nature and Human-Centered Design to ORGATEC 2026

October 26, 2026

Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma

October 26, 2026

Popular News

  • Markel names Chloe Gordge Director of War and Political Violence & Terrorism in London

    0 shares
    Share 0 Tweet 0
  • Hunton Expands Energy and Infrastructure Practices with Addition of Partners Jonathan Brufal in Abu Dhabi and Simon Elliott in Dubai

    0 shares
    Share 0 Tweet 0
  • SOFICO launches SOFICO Intelligence, bringing proactive AI and agentic automation to automotive finance and lease contract management

    0 shares
    Share 0 Tweet 0
  • UN Global Compact Launches Business Integrity Accelerator to Help Companies Fight Corruption

    0 shares
    Share 0 Tweet 0
  • Mantle Marks Major Milestone as $MNT Becomes Available on GMO Coin Following Japan’s Rigorous Asset Review Framework

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler